Date post: | 25-Dec-2015 |
Category: |
Documents |
Upload: | joel-mcgee |
View: | 213 times |
Download: | 1 times |
LINE IN
FECTI
ONS
DIAGNOSIS
AND T
REATMEN
T
HO
S P I TA
L ME D
I CI N
E CU
RR
I CU
LUM
PAM
E L A P
RI D
E MD
, FH
M
ME D
I CA
L UN
I VE R
S I TY O
F SO
UT H
CA
RO
L I NA
MAY 2
1,
20
13
LEARNING OBJECTIVES
1. Differentiate types of infection associated with vascular access
2. Formulate appropriate empiric therapy based on patient specific risk factors
3. Recite indications for antibiotic lock therapy
4. Prescribe appropriate antibiotic therapy based on culture results
INTRODUCTION
>150,000 devices purchased annually by US hospitals
>100,000 deaths $6.5 billion cost Result in average LOS of 12 days longer
in hospital
PATHOPHYSIOLOGY
How do these infections happen?1. Migration of skin flora from insertion site
2. Direct contamination of catheter
3. Hematogenous seeding
4. Contaminated infusate
RISK FACTORSRisk varies based on:
Type of device Midline catheters 0.2% PIV 0.5% PICC 1.1% Tunneled cvc 1.6% Noncuffed cvc 1.7/2.7% PA catheters 3.7%
Use of device
Insertion site (femoral>IJ>SC)
RISK FACTORS Risk varies based on:
Duration of catheter PIV 3-5 days CVC >6 days PA catheter >3-4 days
Frequency of accesses
Use of prevention strategies
Experience and skill of individual
Patient factors
ASK 3 MAIN QUESTIONS
1. What is the nature of the infection?
2. What type of catheter is infected?
3. What is the organism?
What is a CRBSI? Growth of same
organism from percutaneous blood culture and catheter
What is not a CRBSI?Catheter colonizationPhlebitisExit site infectionTunnel InfectionPocket infection
DEFINITIONSWHAT IS A CATHETER RELATED BLOODSTREAM INFECTION (CRBSI)?
MORE DEFINITIONS
Catheter colonization-growth of organism from tip, hub or sq segment of catheter
Phlebitis-redness, warmth, tenderness along tract of catheterized vein
Exit site infection-redness, tenderness or exudate with growth at exit site
Pocket infection-infected fluid in pocket of totally implanted device
Tunnel infection-pain, redness, >2cm from catheter exit site along sq tract of tunneled catheter
Complicated Infection-metastatic foci of bloodstream infection
ASK 3 MAIN QUESTIONS
1. What is the nature of the infection?
2. What type of catheter is infected?
3. What is the organism?
ASK 3 MAIN QUESTIONS
1. What is the nature of the infection?
2. What type of catheter is infected?
3. What is the organism?
EMPIRIC TREATMENTCOVERAGE FOR BACTERIA
Empiric treatment with vanc or dapto depending on hospitals mrsa mic data
Do not use linezolid empirically
Empiric GNR coverage should be based on severity of disease and presence of femoral line
Use cefepime, carbapenem, or zosyn if warranted
Only empirically double cover MDR GNR if pt is one of the following
neutropenic severely septic colonized/recently infected with mdr gnr
Add aminoglycoside if warranted
EMPIRIC TREATMENTCOVERAGE FOR CANDIDAOnly empirically cover candida if pt is
septic AND one of the followingTPNprolonged broad spectrum abxhematologic malignancytransplant ptfemoral sitept colonized with candida at multiple sites
Use echinocandin OR fluconazole if pt has had no azole exposure in past 3 months
MICROBE SPECIFIC TREATMENTCOAG NEGATIVE STAPHNafcillin/oxacillin for msse
Vancomycin for mrse
Treat for 5-7 days with antibiotics if catheter removed
Treat 10-14 days with abx lock if catheter is salvaged
Some say ok to not treat if catheter is removed, pt has no hardware, and blood cx negative after catheter removal
MICROBE SPECIFIC TREATMENTSTAPH AUREUSAlways remove catheter
Nafcillin/oxacillin for mssa
Vanco/dapto for mrsa
Default duration of therapy is 4-6 weeks
Treat 14 days if all following apply
pt not immunosuppressed
catheter is removed
no intravascular devices or grafts
tee negative
no evidence of metastatic infx
bacteremia resolves after 72 hours on abx
Treat 5-7 days for tip cx positive/perc blood cx negative situations
MICROBE SPECIFIC TREATMENTENTEROCOCCUS
Ampicillin is drug of choice if susceptible
Vanco if resistant to amp
Double coverage with aminoglycoside is controversial
7-14 course of therapy recommended
Only tee if other signs and symptoms of endocarditis
MICROBE SPECIFIC TREATMENTGRAM NEGATIVE BACILLI
Carbapenem ok for all following ESBL + ecoli/klebsiella enterobacter serratia acinetobacter
ESBL – e. coli/klebsiella-use 3rd gen cephalosporin
Psuedomonas-4th gen cephalosporin, carbapenem, zosyn, +/- aminoglycoside
Stenotrophomonas- bactrim 3-5mg/kg q8hr
De-escalate asap
Duration of therapy 7-14 days
MICROBE SPECIFIC TREATMENTCANDIDA
Always remove catheter (tunneled hd catheter can be exchanged over wire)
C. Glabrata and C. krusei use echinocandins
C. Albicans use fluconazole 400mg qd
ANTIBIOTIC LOCK THERAPYWHAT IS IT AND WHO CAN GET IT?
For pts with long term cvc’s and uncomplicated
crbsi
Always use with systemic abx
If abx lock not available, give systemic abx through the lumen of the infected catheter
Not for candida or staph aureus crbsi Not for complicated crbsi, exit site or tunnel infx, or
infx with persistent + blood cx after >72 hours of appropriate abx therapy
PEARLS AND PITFALLS
Only culture if infection is suspected
Culture before starting abx
The first day cultures are negative is day one of
abx If unable to obtain percutaneous blood cultures,
drawn cultures from 2 lumens of line
Arterial lines follow the same rules as
temporary cvc’s
PEARLS AND PITFALLS
Do not remove catheters based on fever alone Do not change over guidewire routinely to
prevent infection If you exchange a catheter over a guide wire
and the tip and perc blood cx come back +, you must remove catheter and do fresh stick
When removing the line for suspected crbsi, culture the tip, not the sq segment
For PA catheters culture the introducer tip
PREVENTION
Only place line if necessary, use least risky line in the least risky place that will accomplish your goals
Use full body drape and aseptic technique
Prophylactic systemic abx are not indicated
For pts with hx of crbsi abx lock may be indicated for
prevention
Education, education, education
Checklists